Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

84.28
Delayed Data
As of 1:10pm ET
 +3.60 / +4.46%
Today’s Change
38.43
Today|||52-Week Range
84.56
+8.62%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Obrien Christopher Flint
Chief Medical Officer
Sale5/18/2017105,634$53.32$5.6M+50.58%
Obrien Christopher Flint
Chief Medical Officer
Sale11/02/201745,299$69.71$3.2M+10.85%
Obrien Christopher Flint
Chief Medical Officer
Sale9/05/201752,817$57.50$3.0M+39.03%
Grigoriadis Dimitri E
Chief Research Officer
Sale11/08/201730,000$74.58$2.2M+8.95%
Lloyd Smith Malcolm
Chief Regulatory Officer
Sale1/02/201818,084$77.52$1.4M+1.74%
Gano Kyle
Chief Business Development Officer
Sale9/06/201720,393$60.00$1.2M+37.59%
Gorman Kevin Charles
Chief Executive Officer
Sale5/02/201721,739$53.23$1.2M+49.88%
Lippoldt Darin M
Chief Legal Officer
Sale12/28/201715,237$75.00$1.1M+7.02%
Bozigian Haig P
Chief Development Officer
Sale8/04/201720,000$50.00$1.0M+50.80%
Gorman Kevin Charles
Chief Executive Officer
Sale4/12/201719,290$50.41$972.4K+55.75%
Page of 12